Search

Your search keyword '"Fröhling S"' showing total 511 results

Search Constraints

Start Over You searched for: Author "Fröhling S" Remove constraint Author: "Fröhling S"
511 results on '"Fröhling S"'

Search Results

1. The German Network for Personalized Medicine to enhance patient care and translational research

3. Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial

4. The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma

11. The German Network for Personalized Medicine to enhance patient care and translational research

12. Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma

14. 8P Targeting antiapoptotic Bcl-2 proteins with highly specific BH3 mimetics in solid tumors

15. 99P Fibroblast activation protein alpha (FAP) as theranostic target in solitary fibrous tumor

16. Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers

20. Dissection of CD20 regulation in lymphoma using RNAi

21. Application of precision medicine in clinical routine in haematology - challenges and opportunities

23. 668P Comprehensive analysis of the tumor immune microenvironment (TIM) in advanced adenoid cystic (ACC) and non-adenoid cystic salivary gland cancers (SGC)

24. 1490MO CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT PMO-1601)

25. 487P Randomized phase II study of trabectedin/olaparib compared to physician’s choice in subjects with previously treated advanced or recurrent solid tumors harboring DNA repair deficiencies

28. Chemotherapy and All-Trans Retinoic Acid in Patients >60 Years with Acute Myeloid Leukemia: First Results of the Multicenter Treatment Trial AML HD98-B

29. Stratification of Postremission Therapy in Patients with Acute Myeloid Leukemia < 60 Years According to the Karyotype: Results of the German Multicenter Treatment Trials AML HD93 and AML HD98-A

34. Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway

35. 1533P Gene expression-based prediction of pazopanib benefit in sarcomas

36. High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma*

43. Gene expression-based prediction of pazopanib benefit in sarcomas

45. EORTC SPECTA-AYA: A unique molecular profiling platform for adolescents and young adults with cancer in Europe

46. Molecular characterization of metastatic eccrine porocarcinoma

49. Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

Catalog

Books, media, physical & digital resources